Harlan S. Robins
Chief Scientific Officer, Adaptive Biotechnologies.
Companies
- Adaptive BiotechnologiesChief Scientific Officer Jun 26, 2019 to now1
- EQRx, Inc.Board member Apr 6, 2021 to Apr 6, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Adaptive Biotechnologies ADPT812,058 shares3$19.5M at $24.01Jul 21, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 21, 2026Sold 213,702 shares at $22.12 of Adaptive Biotechnologies3
- Jul 21, 2026Sold 278,698 shares at $21.72 of Adaptive Biotechnologies3
- Jul 21, 2026Exercised options 284,800 shares at $6.55 of Adaptive Biotechnologies3
- Jul 2, 2026Sold 146,889 shares at $22.45 of Adaptive Biotechnologies4
- Jul 2, 2026Sold 239,351 shares at $21.74 of Adaptive Biotechnologies4
- Jun 16, 2026Sold 6,160 shares at $18.01 of Adaptive Biotechnologies5
- Jun 15, 2026Sold 100,000 shares at $17.37 of Adaptive Biotechnologies5
- Apr 8, 2026Sold 10,000 shares at $14.85 of Adaptive Biotechnologies6
- Mar 11, 2026Sold 329,600 shares at $13.17 of Adaptive Biotechnologies7
- Mar 11, 2026Sold 140,666 shares at $13.17 of Adaptive Biotechnologies7
- Mar 6, 2026Granted 709,220 shares of Adaptive Biotechnologies8
- Mar 4, 2026Granted 127,813 shares of Adaptive Biotechnologies8
- Mar 3, 2026Sold 14,233 shares at $16.52 of Adaptive Biotechnologies9
- Mar 2, 2026Sold 10,000 shares at $15.72 of Adaptive Biotechnologies9
- Feb 3, 2026Sold 8,120 shares at $19.00 of Adaptive Biotechnologies10
- Feb 2, 2026Sold 34,668 shares at $18.60 of Adaptive Biotechnologies10
- Jan 6, 2026Sold 10,000 shares at $16.44 of Adaptive Biotechnologies11
- Dec 4, 2025Sold 10,000 shares at $16.61 of Adaptive Biotechnologies12
- Dec 3, 2025Sold 27,212 shares at $18.61 of Adaptive Biotechnologies12
- Nov 10, 2025Sold 10,000 shares at $14.82 of Adaptive Biotechnologies13
- May 1, 2025Sold 68,412 shares at $7.35 of Adaptive Biotechnologies14
- May 1, 2025Exercised options 68,412 shares at $6.32 of Adaptive Biotechnologies14
- Mar 24, 2025Sold 1,698 shares at $9.00 of Adaptive Biotechnologies15
- Mar 24, 2025Exercised options 1,698 shares at $6.32 of Adaptive Biotechnologies15
- Mar 5, 2025Sold 56,053 shares at $6.99 of Adaptive Biotechnologies16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGAREQRx, Inc., Board member
- 3
- 4SEC EDGARForm 4 filed Jul 7, 2026
- 5SEC EDGARForm 4 filed Jun 17, 2026
- 6SEC EDGARForm 4 filed Apr 10, 2026
- 7SEC EDGARForm 4 filed Mar 13, 2026
- 8SEC EDGARForm 4 filed Mar 6, 2026
- 9SEC EDGARForm 4 filed Mar 4, 2026
- 10SEC EDGARForm 4 filed Feb 4, 2026
- 11SEC EDGARForm 4 filed Jan 8, 2026
- 12SEC EDGARForm 4 filed Dec 5, 2025
- 13SEC EDGARForm 4 filed Nov 12, 2025
- 14SEC EDGARForm 4 filed May 5, 2025
- 15SEC EDGARForm 4 filed Mar 26, 2025
- 16SEC EDGARForm 4 filed Mar 6, 2025